Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Adrenal hemangioma-adenoma: An exceedingly rare adrenal collision tumor
Journal of Magnetic Resonance Imaging, 03/25/09
Siddiqi AJ et al. - Adrenal collision tumors are rare clinical entities referring to separate coexisting adjacent tumors involving an adrenal gland with sharp demarcation between the two and without a substantial histologic admixture at the interface.
Related Articles
Collision tumor of the stomach: Gastric adenocarcinoma intermixed with gastrointestinal stromal tumor
Pathology International, 10/20/09
Relevance Score: 69%
Invasive ductal breast cancer within a malignant phyllodes tumor: case report and assessment of clonality
Human Pathology, 11/12/09
Relevance Score: 67%
Infiltrating glomus tumor of uncertain malignant potential arising in the kidney
Human Pathology, 11/12/09
Relevance Score: 47%
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer
Journal of Clinical Oncology, 10/30/09
Relevance Score: 46%
Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
Journal of Neuro-Oncology, 10/26/09
Relevance Score: 46%
Today in Adrenal Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma
Journal of Clinical Endocrinology and Metabolism, 12/17/09
Ultrasound-assisted Microsurgery for Cushing's Disease
Experimental and Clinical Endocrinology & Diabetes, 12/17/09
Diagnosis and Treatment of Adrenal Tumors: A Single-Center Experience with 238 Cases
Urologia Internationalis, 12/17/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/17/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/17/09
Emerging targeted therapies for bladder cancer: a disease waiting for a drug
Cancer and Metastasis Reviews, 12/17/09
Article Search
Sponsor


See Latest Articles


